CompuMed Extends Dominance In Correctional Market For Remote ECG Screening With Latest Statewide Contract

LOS ANGELES, Oct. 27 /PRNewswire-FirstCall/ -- CompuMed, Inc. (BULLETIN BOARD: CMPD) -- a medical informatics company serving the healthcare community with diagnostic software solutions -- today announced that it has won a five-year contract renewal to provide electrocardiogram (ECG) interpretation systems and services for the Oklahoma Department of Corrections (ODOC).

With this contract, Oklahoma becomes the latest in a growing number of states to award new contracts or extend existing contracts to use CompuMed's CardioGram remote ECG system. The company recently announced that correctional departments in New York, California, Nevada, and New Mexico have selected the CardioGram for screening inmates.

"We are pleased to win this latest contract bid from yet another valued state correctional department client," said Jerry McLaughlin, CompuMed's CEO. "The CardioGram significantly reduces health care costs for these clients by reducing unnecessary trips to offsite medical facilities."

Under the terms of the contract, 20 ODOC detention facilities will use the CardioGram and related interpretation services to conduct remote cardiac screening. ODOC houses more than 15,000 inmates statewide.

CompuMed's traditional core business is providing remote ECG interpretation services to medical facilities that may not have access to physicians trained and qualified to interpret ECG results. Customers for the Company's CardioGram system are typically correctional facilities, ambulatory surgery centers, occupational health clinics and physicians' offices. One of the CardioGram's many advantages is an optional feature that automatically sends ECG results to a trained cardiologist for an over-read when the results are abnormal.

About CompuMed:

Founded in 1973, CompuMed, Inc. (BULLETIN BOARD: CMPD) is a leading provider of computer-aided telemedicine and diagnostics technology. The company's core products are the OsteoGram and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate healthcare providers nationwide. The CardioGram has the additional capability to automatically provide an over-read by a cardiologist. CompuMed is headquartered in Los Angeles. Visit CompuMed at http://www.compumed.net/.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks defined in this document. All such forward-looking statements whether written or oral, and whether made by or on behalf of the Company are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

CompuMed, Inc.

CONTACT: Erik Deutsch of Tellem Worldwide, +1-310-479-6111, ext. 15,edeutsch@tellem.com, for CompuMed, Inc.

Back to news